Stocks and Investing
Stocks and Investing
Fri, October 7, 2022
[ 12:00 AM ] - United States, WOPRAI
[ 12:00 AM ] - United States, WOPRAI
[ 12:00 AM ] - United States, WOPRAI
[ 12:00 AM ] - United States, WOPRAI
[ 12:00 AM ] - United States, WOPRAI
[ 12:00 AM ] - United States, WOPRAI
[ 12:00 AM ] - United States, WOPRAI
[ 12:00 AM ] - United States, WOPRAI
[ 12:00 AM ] - United States, WOPRAI
[ 12:00 AM ] - United States, WOPRAI
[ 12:00 AM ] - United States, WOPRAI
[ 12:00 AM ] - United States, WOPRAI
[ 12:00 AM ] - United States, WOPRAI
[ 12:00 AM ] - United States, WOPRAI
[ 12:00 AM ] - United States, WOPRAI
[ 12:00 AM ] - United States, WOPRAI
[ 12:00 AM ] - United States, WOPRAI
[ 12:00 AM ] - United States, WOPRAI
[ 12:00 AM ] - United States, WOPRAI
[ 12:00 AM ] - United States, WOPRAI
[ 12:00 AM ] - United States, WOPRAI
Thu, October 6, 2022
[ 12:00 AM ] - United States, WOPRAI
[ 12:00 AM ] - United States, WOPRAI
[ 12:00 AM ] - United States, WOPRAI
[ 12:00 AM ] - United States, WOPRAI
[ 12:00 AM ] - United States, WOPRAI
[ 12:00 AM ] - United States, WOPRAI
Luke Sergott Maintained (TWST) at Buy with Decreased Target to $45 on, Oct 6th, 2022
Luke Sergott of Barclays, Maintained "Twist Bioscience Corporation" (TWST) at Buy with Decreased Target from $55 to $45 on, Oct 6th, 2022.
Luke has made no other calls on TWST in the last 4 months.
There is 1 other peer that has a rating on TWST. Out of the 1 peers that are also analyzing TWST, all agrees with Luke's Rating of Hold. Following is the relevant analyst calls for the last 4 months
- Puneet Souda of "SVB Leerink" Maintained at Hold with Increased Target to $50 on, Monday, August 8th, 2022
Contributing Sources